Longitudinal tracking of cytokines after acute exposure to tuberculosis: Association of distinct cytokine patterns with protection and disease development

Clinical and Vaccine Immunology

Volumn 14, Issue 12, 2007, Pages 1578-1586

  Hussain, Rabia ^a   Talat, Najeeha ^a   Shahid, Firdaus ^a   Dawood, Ghaffar ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Masoomeen General Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MYCOBACTERIUM ANTIGEN; PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FAMILY HEALTH; FEMALE; HUMAN; HUMAN CELL; INFECTION CONTROL; INFECTION RISK; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CELLS, CULTURED; COHORT STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MITOGENS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PEDIGREE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 38049051806     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00289-07     Document Type: Article

References (51)

1. Akhtar, S., T. E. Carpenter, and S. K. Rathi. 2007. A chain binomial model for intra-household spread of Mycobacterium tuberculosis in a low socioeconomic setting in Pakistan. Epidemiol. Infect. 135:27-33.
2. Akhtar, S., F. White, R. Hasan, S. Rozi, M. Younus, F. Ahmed, S. Husain, and B. S. Khan. 2007. Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health 7:70.
3. Antas, P. R. Z., F. L. L. Cardoso, K. C. Pereira, K. L. Franken, K. S. Cunha, P. Klatser, E. N. Sarno, T. H. M. Ottenhoff, and E. P. Sampaio. 2005. T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls. Trans. R. Soc. Trop. Med. Hyg. 99:699-707.
4. Balkhi, M. Y., A. Sinha, and K. Natarajan. 2004. Dominance of CD86, transforming growth factor-β1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens. J. Infect. Dis. 189:1598-1609.
5. Becerra, M. C., I. F. Pachao-Torreblanca, J. Bayona, R. Celi, S. S. Shin, J. Y. Kim, P. E. Farmer, and M. Murray. 2005. Expanding tuberculosis case detection by screening household contacts. Public Health Rep. 120:271-277.
6. Binkin, N. J., A. A. Vernon, P. M. Simone, E. McCray, B. I. Miller, C. W. Schieffelbein, and K. G. Castro. 1999. Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int. J. Tuberc. Lung Dis. 3:663-674.
7. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, K. Branson, S. D. Chaguluka, L. Donovan, E. Jarman, E. King, P. E. M. Fine, and H. M. Dockrell. 2002. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401.
8. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Investig. 105:1317-1325.
9. Brahmbhatt, S., G. F. Black, N. M. Carroll, N. Beyers, F. Salker, M. Kidd, P. T. Lukey, K. Duncan, P. van Helden, and G. Walzl. 2006. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin. Exp. Immunol. 146:243-252.
10. Carrara, S., D. Vincenti, N. Petrosillo, M. Amicosante, E. Girardi, and D. Goletti. 2004. Use of a T cell based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38:754-756.
11. Chee, C. B. E., K. W. KhinMar, S. H. Gan, T. M. Barkham, M. Pushparani, and Y. T. Wang. 2007. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am. J. Respir. Crit. Care Med. 175:282-287.
12. Comstock, G. W. 1988. Identification of an effective vaccine against tuberculosis. Am. Rev. Respir. Dis. 138:479-480.
13. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene disrupted mice. J. Exp. Med. 178:2243-2247.
14. Cosma, C. L., D. R. Sherman, and L. Ramakrishnan. 2003. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57:641-676.
15. Demissie, A., L. Wassie, M. Abebe, A. Aseffa, G. Rook, A. Zumla, P. Andersen, T. M. Doherty, and VACSEL Study Group. 2006. The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect. Immun. 74:2817-2822.
16. Dhingra, V. K., S. Rajpal, N. Aggarwal, and D. K. Taneja. 2004. Tuberculosis trend among house hold contacts of TB patients. Indian J. Comm. Med. 29:1-3.
17. Elliot, A. M., W. S. Hodsdon, J. Kyosiimire, M. A. Quigley, J. S. Nakiyingi, P. B. Namujju, C. Watera, N. French, C. F. Gilks, H. M. Dockrell, and J. A. G. Whitworth. 2004. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans. R. Soc. Trop. Med. Hyg. 98:660-670.
18. Elliott, A. M. T. J. Hurst, M. N. Balyeku, M. A. Quigley, P. Kaleebu, N. French, B. Biryahwaho, J. A. G. Whitworth, H. M. Dockrell, and R. J. Hayes. 1999. The immune response to Mycobacterium tuberculosis in HIV infection and uninfected adults in Uganda: application of a whole blood cytokine assay in a epidemiological study. Int. J. Tuberc. Lung Dis. 3:239-247.
19. Ewer, K., K. A. Millington, J. J. Deeks, L. Alvarez, G. Bryant, and A. Lalvani. 2006. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174:831-839.
20. Ferrand, R. A., G. H. Bothamley, A. Whelan, and H. M. Dockrell. 2005. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int. J. Tuberc. Lung Dis. 9:1-6.
21. Fine, P. E. M. 1989. The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. 11 (Suppl. 2):S353-S359.
22. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
23. + memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 194:984-992.
24. Guwatudde, D., M. Nakakeeto, E. C. Jones-Lopez, A. Maganda, A. Chiunda, R. D. Mugerwa, J. J. Ellner, G. Bukenya, and C. C. Wahlen. 2003. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am. J. Epidemiol. 158:887-898.
25. Hussain, R., R. Hasan, M. Khurshid, A. W. Sturm, J. J. Ellner, and G. Dawood. 1996. Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns. Southeast Asian J. Trop. Med. Public Health 27:257-262.
26. Hussain, R., A. Kaleem, F. Shahid, M. Dojki, B. Jamil, H. Mehmood, G. Dawood, and H. M. Dockrell. 2002. Cytokine profiles using whole blood assays can discriminate between tuberculosis patients and healthy endemic controls in BCG-vaccinated population. J. Immunol. Methods 264:95-108.
27. Jamil, B., F. Shahid, Z. Hasan, N. Nasir, T. Razzaki, G. Dawood, and R. Hussain. 2007. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinburgh) 87:279-287.
28. Jasmer, R. M., P. Nahid, and P. C. Hopewell. 2002. Latent tuberculosis infection. N. Engl. J. Med. 347:1860-1866.
29. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171:6323-6327.
30. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J.-L. Casanova. 1996. Interferon gamma receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961.
31. Katakura, T., M. Miyazaki, M. Kobayashi, D. N. Herndon, and F. Suzuki. 2004. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172:1407-1413.
32. Kolk, A. H. J., R. Evers, D. G. Groothuis, H. Gilis, and S. Kuijper. 1989. Production and characterization of monoclonal antibodies against specific serotypes of Mycobacterium avium and the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex. Infect. Immun. 57:2514-2521.
33. Lemos, A. C., E. D. Matos, D. B. Pedral-Sampaio, and E. M. Netto. 2004. Risk of tuberculosis among household contacts in Salvador, Bahia. Braz. J. Infect. Dis. 8:424-430.
34. Lienhardt, C. 2001. From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol. Rev. 23:288-301.
35. Meneghin, A., and C. M. Hogaboam. 2007. Infectious disease, the innate immune response, and fibrosis. J. Clin. Investig. 117:530-538.
36. Millington, K. A., J. A. Innes, S. Hackforth, T. S. C. Hinks, J. J. Deeks, D. P. S Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFNγ and IL12 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178:5217-5226.
37. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon γ receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
38. + Tregs: limiting collateral damage. J. Clin. Investig. 114:1372-1378.
39. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. S. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFNγ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:5217- 5225.
40. Rathi, S. K., S. Akhtar, M. H. Rahbar, and S. I. Azam. 2002. Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulmonary tuberculosis cases in Umerkot, Pakistan. Int J. Tuberc. Lung Dis. 6:851-857.
41. + T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144:25-34.
42. Sahiratmadja, E., B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. H. Nelwan, S. Marzuki, J. W. van der Meer, R. van Crevel, E. van de Vosse, and T. H. M. Ottenhoff. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829.
43. Thakurdas, S. M., Z. Hasan, and R. Hussain. 2004. IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-α) secreted by mycobacterial antigen stimulated adherent cells. Clin. Exp. Immunol. 136:320-327.
44. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169:6343-6351.
45. Vekemans, J., C. Lienhardt, J. S. Sillah, J. G. Wheeler, G. P. Lahai, M. T. Doherty, T. Corrah, P. Andersen, K. P. W. J. McAdam, and A. Marchant. 2001. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect. Immun. 69:6554-6557.
46. Verbon, A., S. Kuijper, H. M. Jansen, P. Speelman, and A. H. J. Kolk. 1990. Antigen in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J. Gen. Microbiol. 136:955-964.
47. Verver, S., R. M. Warren, Z. Munch, M. Richardson, G. D. van der Spuy, M. W. Borgdorff, M. A. Behr, N. Beyers, and P. D. van Helden. 2004. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 363:212-214.
48. WHO. 2006. TB report (Pakistan), p. 110-112. WHO, Geneva, Switzerland.
49. Wilkinson, K. A., O. M. Kon, S. M. Newton, G. Meintjes, R. N. Davidson, G. Pasvol, and R. J. Wilkinson. 2006. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J. Infect. Dis. 193:354-359.
50. Wilkinson, K. A., R. J. Wilkinson, A. Pathan, K. Ewer, M. Prakash, P. Klenerman, N. Maskell, R. Davies, G. Pasvol, and A. Lalvani. 2005. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin. Infect. Dis. 40:184-187.
51. Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234.